These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34788697)

  • 1. Selective impairment of timing in a NMDA hypofunction animal model of psychosis.
    Maleninska K; Jandourkova P; Brozka H; Stuchlik A; Nekovarova T
    Behav Brain Res; 2022 Feb; 419():113671. PubMed ID: 34788697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A; Vales K
    Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
    van der Staay FJ; Rutten K; Erb C; Blokland A
    Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dizocilpine (MK-801) impairs learning in the active place avoidance task but has no effect on the performance during task/context alternation.
    Vojtechova I; Petrasek T; Hatalova H; Pistikova A; Vales K; Stuchlik A
    Behav Brain Res; 2016 May; 305():247-57. PubMed ID: 26970577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two learning tasks provide evidence for disrupted behavioural flexibility in an animal model of schizophrenia-like behaviour induced by acute MK-801: a dose-response study.
    Lobellova V; Entlerova M; Svojanovska B; Hatalova H; Prokopova I; Petrasek T; Vales K; Kubik S; Fajnerova I; Stuchlik A
    Behav Brain Res; 2013 Jun; 246():55-62. PubMed ID: 23499708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats.
    Vales K; Bubenikova-Valesova V; Klement D; Stuchlik A
    Neurosci Res; 2006 Aug; 55(4):383-8. PubMed ID: 16712995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha(1)-adrenergic antagonist prazosin on behavioral alterations induced by MK-801 in a spatial memory task in Long-Evans rats.
    Stuchlík A; Petrásek T; Vales K
    Physiol Res; 2009; 58(5):733-740. PubMed ID: 19093715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a novel Active Allothetic Place Avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: comparison with the Morris Water Maze.
    Stuchlik A; Rezacova L; Vales K; Bubenikova V; Kubik S
    Neurosci Lett; 2004 Aug; 366(2):162-6. PubMed ID: 15276239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher doses of (+)MK-801 (dizocilpine) induced mortality and procedural but not cognitive deficits in delayed testing in the active place avoidance with reversal on the Carousel.
    Lobellová V; Brichtová E; Petrásek T; Valeš K; Stuchlík A
    Physiol Res; 2015; 64(2):269-75. PubMed ID: 25317686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A therapeutic dose of memantine improves the performance of rats in an active place avoidance task under the continuous dissociation of distal room and proximal arena cues.
    Wesierska M; Svoboda J; Stuchlik A
    Neurobiol Learn Mem; 2019 Jul; 162():59-66. PubMed ID: 31085330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GABA-B receptors in the basolateral amygdala on passive avoidance memory impairment induced by MK-801 in rats.
    Khakpoor M; Vaseghi S; Mohammadi-Mahdiabadi-Hasani MH; Nasehi M
    Behav Brain Res; 2021 Jul; 409():113313. PubMed ID: 33891976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats.
    Wang X; Luo C; Mao XY; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ
    Brain Res; 2019 Sep; 1719():30-39. PubMed ID: 31121159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial prefrontal administration of MK-801 impairs T-maze discrimination reversal learning in weanling rats.
    Watson DJ; Stanton ME
    Behav Brain Res; 2009 Dec; 205(1):57-66. PubMed ID: 19643149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute NMDA receptor antagonism impairs working memory performance but not attention in rats-Implications for the NMDAr hypofunction theory of schizophrenia.
    Lee J; van den Buuse M; Nithianantharajah J; Jones NC
    Behav Neurosci; 2020 Aug; 134(4):323-331. PubMed ID: 32658524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
    Talpos J; Aerts N; Waddell J; Steckler T
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early enriched environment prevents cognitive impairment in an animal model of schizophrenia induced by MK-801: Role of hippocampal BDNF.
    Faatehi M; Basiri M; Nezhadi A; Shabani M; Masoumi-Ardakani Y; Soltani Z; Nozari M
    Brain Res; 2019 May; 1711():115-119. PubMed ID: 30677409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the N-methyl-d-aspartate receptor antagonist, MK-801, on spatial memory and influence of the route of administration.
    Svalbe B; Stelfa G; Vavers E; Zvejniece B; Grinberga S; Sevostjanovs E; Pugovics O; Dambrova M; Zvejniece L
    Behav Brain Res; 2019 Oct; 372():112067. PubMed ID: 31276703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments.
    Zhang C; Fang Y; Xu L
    Schizophr Res; 2014 Nov; 159(2-3):376-84. PubMed ID: 25219486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.